These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16387340)

  • 41. Inferring HIV Escape Rates from Multi-Locus Genotype Data.
    Kessinger TA; Perelson AS; Neher RA
    Front Immunol; 2013; 4():252. PubMed ID: 24027569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction of arbitrarily strong amplifiers of natural selection using evolutionary graph theory.
    Pavlogiannis A; Tkadlec J; Chatterjee K; Nowak MA
    Commun Biol; 2018; 1():71. PubMed ID: 30271952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silence, escape and survival drive the persistence of HIV.
    Chomont N
    Nature; 2023 Feb; 614(7947):236-237. PubMed ID: 36599993
    [No Abstract]   [Full Text] [Related]  

  • 44. Distribution of escape times in a driven stochastic model.
    Casado JM; Morillo M
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 1994 Feb; 49(2):1136-1139. PubMed ID: 9961321
    [No Abstract]   [Full Text] [Related]  

  • 45. The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.
    Batorsky R; Sergeev RA; Rouzine IM
    PLoS Comput Biol; 2014 Oct; 10(10):e1003878. PubMed ID: 25356981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 Subtype C Phylodynamics in the Global Epidemic.
    Novitsky V; Wang R; Lagakos S; Essex M
    Viruses; 2010 Jan; 2(1):33-54. PubMed ID: 21994599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
    Ganusov VV; Goonetilleke N; Liu MK; Ferrari G; Shaw GM; McMichael AJ; Borrow P; Korber BT; Perelson AS
    J Virol; 2011 Oct; 85(20):10518-28. PubMed ID: 21835793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1.
    Balagam R; Singh V; Sagi AR; Dixit NM
    PLoS One; 2011 Jan; 6(1):e14531. PubMed ID: 21249189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.
    O'Connor SL; Lhost JJ; Becker EA; Detmer AM; Johnson RC; Macnair CE; Wiseman RW; Karl JA; Greene JM; Burwitz BJ; Bimber BN; Lank SM; Tuscher JJ; Mee ET; Rose NJ; Desrosiers RC; Hughes AL; Friedrich TC; Carrington M; O'Connor DH
    Sci Transl Med; 2010 Mar; 2(22):22ra18. PubMed ID: 20375000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics of immune escape during HIV/SIV infection.
    Althaus CL; De Boer RJ
    PLoS Comput Biol; 2008 Jul; 4(7):e1000103. PubMed ID: 18636096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GENOMEPOP: a program to simulate genomes in populations.
    Carvajal-Rodríguez A
    BMC Bioinformatics; 2008 Apr; 9():223. PubMed ID: 18447924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental evolution and genome sequencing reveal variation in levels of clonal interference in large populations of bacteriophage phiX174.
    Pepin KM; Wichman HA
    BMC Evol Biol; 2008 Mar; 8():85. PubMed ID: 18366653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modelling the evolution of drug resistance in the presence of antiviral drugs.
    Wu J; Yan P; Archibald C
    BMC Public Health; 2007 Oct; 7():300. PubMed ID: 17953775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
    Liu Y; McNevin J; Zhao H; Tebit DM; Troyer RM; McSweyn M; Ghosh AK; Shriner D; Arts EJ; McElrath MJ; Mullins JI
    J Virol; 2007 Nov; 81(22):12179-88. PubMed ID: 17728222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
    Mandl JN; Regoes RR; Garber DA; Feinberg MB
    J Virol; 2007 Nov; 81(21):11982-91. PubMed ID: 17699572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV viral diversity and escape from cellular immunity.
    Frahm N; Brander C
    Curr Infect Dis Rep; 2007 Mar; 9(2):161-6. PubMed ID: 17324354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
    Liu Y; Mullins JI; Mittler JE
    Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
    Wodarz D; Levy DN
    Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
    Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.